GO
Loading...

Novartis AG

More

  • Your First Move For Friday October 17th Thursday, 16 Oct 2008 | 6:58 PM ET

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • Lightning Round: Transocean, Verizon, Deere and More Wednesday, 8 Oct 2008 | 10:13 PM ET

    Cramer makes the call on viewers' favorite stocks.

  • Could The Credit Crisis Help Pfizer? Monday, 6 Oct 2008 | 3:46 PM ET

    Pretty much all of biopharma is caught in the downdraft of the markets today with the notable exception of Dendreon (data) and ImClone Systems (a deal).

  • Your First Move For Monday October 6th Friday, 3 Oct 2008 | 7:18 PM ET

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • Stocks Slammed; Will Bailout Be Enough? Thursday, 2 Oct 2008 | 6:04 PM ET

    Investors hammered the Dow on Thursday as fear grew that even a $700 billion bailout won’t be enough to counter tight credit markets and a bleak economy.

  • Your First Move For Thursday October 2nd Wednesday, 1 Oct 2008 | 6:48 PM ET

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • Chartology: Is The Bottom In Wednesday, 1 Oct 2008 | 6:16 PM ET

    The Fast Money traders told you the bottom won’t be in, until there’s panic like never before. Wait...

  • Stocks Fall On Bailout Uncertainty Wednesday, 1 Oct 2008 | 5:41 PM ET

    The Dow closed lower on Wednesday as nervous investors found it difficult to muster enthusiasm ahead of the Senate’s vote on a revamped $700 billion rescue plan.

  • Web Extra: Defense, Defense Wednesday, 17 Sep 2008 | 6:49 PM ET

    Evidently you can run... and you 'can' hide. Find out where the traders think you should seek shelter from the current storm.

  • How Do You Trade A Day Like Today? Wednesday, 17 Sep 2008 | 6:18 PM ET

    Find out what strategies the Fast Money traders are using to navigate this murderous market!

  • Sifting Through The Rubble Monday, 15 Sep 2008 | 6:12 PM ET

    Which stocks were unfairly punished during Monday’s monster sell-off?

  • Charts Point to European Drug Stocks Thursday, 11 Sep 2008 | 7:56 AM ET

    Of all the places to put money to work in Europe, the pharmaceutical sector is the most promising, a technical analyst told CNBC Thursday.

  • Your First Move For Wednesday September 10th Tuesday, 9 Sep 2008 | 7:42 PM ET

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • Abbott's Covering The Bases Thursday, 14 Aug 2008 | 1:28 PM ET

    The market cap of Dow component Johnson & Johnson is a whopping $200 billion. Abbott Labs is valued at less than half that. But think of ABT as kind of a mini-me JNJ because like Johnson & Johnson, ABT has cobbled together a similar three-siloed business of drugs, devices and consumer products.

  • Web Extra: Deere In The Headlights Wednesday, 13 Aug 2008 | 7:09 PM ET

    In Wednesday’s Web Extra the traders talk Deere & Co. Find out if this 'ag' name could grow your portfolio. Also Guy Adami has a biotech trade for you.

  • Bullish On Biotech Thursday, 31 Jul 2008 | 4:01 PM ET

    Bristol Myers offered a cool $4.5 billion for ImClone Thursday. Is now the time to play biotech?

  • Markets Best Sector Friday, 25 Jul 2008 | 6:52 PM ET

    In the last month healthcare has emerged as the best performing sector in the S&P. Are drug makers a cure for your portfolio in this economic downturn?

  • Big Pharma Is Scrambling To Buy More Biotech Firms Monday, 21 Jul 2008 | 11:11 AM ET

    Roche Holdings' $43.7 billion bid to buy the rest of Genentech highlights drugmakers' growing reliance on biotech products.

  • Roche Offers to Buy Out Genentech for $43.7 Billion Monday, 21 Jul 2008 | 6:33 AM ET

    Swiss drugmaker Roche Holding offered to acquire all outstanding shares in its U.S. partner Genentech for $43.7 billion in cash to reinforce its position in cancer medicines.

  • Web Extra: Beware Of Broken China? Thursday, 17 Jul 2008 | 7:00 PM ET

    In Thursday’s Web Extra the traders talk China – now growing at its slowest pace since 2005. Also Pete Najarian has more fun with Pharma.